Pharmaceutical Division

  • Our major field of business is undoubtedly the import of pharmaceuticals.
  • It was established in 1993 under the management of Dr. Tarig Mohy Aldin, Chairman of the Board and General Manager.
  • The Fast International board of directors allocated a separate budget for this project amounting to the sum of USD 700,000.
  • Today the Pharmaceutical Division has capital of approximately USD 12 million.
  • Initially, It commenced with the distribution of drugs produced by Hikma Pharmaceuticals of Jordan and disposable syringes from the Medical Jordanian Corporation (MJC).

At present Fast International is the agent of the following pharmaceutical companies:

  • Hikma – Jordan
  • Micro Labs – India          
  • October Pharma – Egypt
  • Ibsa Institut – Switzerland
  • Saja – Saudia Arabia
  • AVVA Pharm.Ltd – Cyprus
  • Novartis Egypt
  • Al Taqaddom Company – Jordan

  • Labatec Pharma- Switzerland
  • Marcyrl Pharmaceuticals – Egypt
  • Hetero Drugs – India
  • Marcal & Marvit – Egypt
  • Loli Pharma – Italy
  • Ioltech-France
  • MANX- UK
  • Biomet Merck-Germany
  • Brock beauty Inc. – USA
  • Rameda Egypt
  • Wellbiotics H. Sciences – USA
  • In 2020, we are forecasting turnover more that 30M USD sales out It was the only private company to implement distribution channels in remote areas by outstation offices serve.
    Branch offices in:
  • Red Sea State (Port Sudan)
  • Al Jazera State (Medani)
  • Kasala State (Kassala)
  • Shamal Kordofan State (El-Obeid)
     to facilitate payment and delivery.
  • Moreover, we have established our sister company in South Sudan, City of Juba.
Scroll to top